Human Investing’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $810K | Sell |
3,191
-4
| -0.1% | -$932 | 0.11% | 50 |
|
|
2026
Q1 | $781K | Sell |
3,195
-136
| -4% | -$31.7K | 0.11% | 50 |
|
|
2025
Q4 | $689K | Sell |
3,331
-237
| -7% | -$46.9K | 0.1% | 53 |
|
|
2025
Q3 | $662K | Buy |
3,568
+225
| +7% | +$38.5K | 0.1% | 52 |
|
|
2025
Q2 | $511K | Sell |
3,343
-387
| -10% | -$59.5K | 0.08% | 58 |
|
|
2025
Q1 | $619K | Buy |
3,730
+38
| +1% | +$5.95K | 0.11% | 50 |
|
|
2024
Q4 | $534K | Sell |
3,692
-732
| -17% | -$113K | 0.09% | 57 |
|
|
2024
Q3 | $717K | Sell |
4,424
-221
| -5% | -$35.2K | 0.13% | 48 |
|
|
2024
Q2 | $679K | Sell |
4,645
-524
| -10% | -$77.9K | 0.13% | 47 |
|
|
2024
Q1 | $818K | Sell |
5,169
-255
| -5% | -$40.6K | 0.16% | 42 |
|
|
2023
Q4 | $850K | Sell |
5,424
-1,264
| -19% | -$194K | 0.18% | 39 |
|
|
2023
Q3 | $1.04M | Sell |
6,688
-276
| -4% | -$45.5K | 0.24% | 36 |
|
|
2023
Q2 | $1.15M | Buy |
6,964
+872
| +14% | +$141K | 0.26% | 36 |
|
|
2023
Q1 | $944K | Buy |
6,092
+13
| +0.2% | +$2.1K | 0.23% | 41 |
|
|
2022
Q4 | $1.07M | Sell |
6,079
-863
| -12% | -$149K | 0.27% | 41 |
|
|
2022
Q3 | $1.13M | Sell |
6,942
-168
| -2% | -$28.4K | 0.29% | 44 |
|
|
2022
Q2 | $1.26M | Buy |
7,110
+22
| +0.3% | +$3.92K | 0.3% | 46 |
|
|
2022
Q1 | $1.26M | Buy |
+7,088
| New | +$1.21M | 0.28% | 51 |
|
|
2021
Q4 | – | Sell |
-7,406
| Closed | -$1.2M | – | 93 |
|
|
2021
Q3 | $1.2M | Sell |
7,406
-41
| -0.6% | -$7K | 0.28% | 54 |
|
|
2021
Q2 | $1.23M | Sell |
7,447
-219
| -3% | -$36.3K | 0.3% | 54 |
|
|
2021
Q1 | $1.26M | Sell |
7,666
-441
| -5% | -$71.4K | 0.32% | 49 |
|
|
2020
Q4 | $1.28M | Buy |
8,107
+22
| +0.3% | +$3.25K | 0.36% | 51 |
|
|
2020
Q3 | $1.2M | Sell |
8,085
-5,461
| -40% | -$808K | 0.4% | 63 |
|
|
2020
Q2 | $1.91M | Sell |
13,546
-1,358
| -9% | -$198K | 0.67% | 32 |
|
|
2020
Q1 | $1.95M | Sell |
14,904
-1,561
| -9% | -$221K | 0.85% | 23 |
|
|
2019
Q4 | $2.4M | Sell |
16,465
-249
| -1% | -$33.8K | 0.78% | 30 |
|
|
2019
Q3 | $2.16M | Sell |
16,714
-1,077
| -6% | -$142K | 0.77% | 33 |
|
|
2019
Q2 | $2.48M | Sell |
17,791
-146
| -0.8% | -$20.2K | 0.9% | 22 |
|
|
2019
Q1 | $2.51M | Sell |
17,937
-701
| -4% | -$93.9K | 0.94% | 25 |
|
|
2018
Q4 | $2.4M | Buy |
+18,638
| New | +$2.6M | 1% | 25 |
|
Other funds holding JNJ
Human Investing's JNJ Position: Q2 2026 in Review
Human Investing reduced its Johnson & Johnson (JNJ) stake by 0.13% in Q2 2026, selling an estimated $932 and leaving 3,191 shares worth $810K. The position accounts for 0.11% of the portfolio, ranked #50.
Human Investing first reported a position in JNJ in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.51M in Q1 2019. 4,689 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Human Investing held 3,191 shares of Johnson & Johnson worth $810K as of Q2 2026.
- Human Investing sold 4 Johnson & Johnson shares in Q2 2026, an estimated $932.
- Johnson & Johnson made up 0.11% of Human Investing's portfolio in Q2 2026, its #50 holding.
- Human Investing first reported a position in Johnson & Johnson in Q4 2018 and has held it in 30 quarters since.
- Human Investing's Johnson & Johnson position peaked at $2.51M in Q1 2019.
- 4,689 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Human Investing's 13F filing for Q2 2026, filed 20 Jul 2026.